نتایج جستجو برای: doxorubicin

تعداد نتایج: 29822  

Journal: :Experimental oncology 2009
N V Rusetskaya N Yu Lukyanova V F Chekhun

AIM To compare the molecular profile and cell cycle of sensitive and resistant to doxorubicin MCF-7 breast cancer cells upon exposition to conventional or liposome-encapsulated forms of doxorubicin. METHODS capital EM, Cyrilliccapital TE, Cyrilliccapital TE, Cyrillic-test, immunocytochemistry, flow cytometry. RESULTS In sensitive MCF-7 cells the exposure to conventional but not liposomal fo...

Journal: :Reactions Weekly 2021

In addition to increasing the efficacy of various drugs, Nanoparticles reduce their side effects. In this study, different nanoparticle formulations of Doxorubicin anticancer drugs were prepared. The efficacy of the formulations produced in the cell culture medium was studied compared with the free drug. Reverse phase evaporation was used to form the liposome containing do...

2014
Jaromir Gumulec Michaela Fojtu Martina Raudenska Marketa Sztalmachova Anna Skotakova Jana Vlachova Sylvie Skalickova Lukas Nejdl Pavel Kopel Lucia Knopfova Vojtech Adam Rene Kizek Marie Stiborova Petr Babula Michal Masarik

Doxorubicin is an effective chemotherapeutic drug, however, its toxicity is a significant limitation in therapy. Encapsulation of doxorubicin inside liposomes or ferritin cages decreases cardiotoxicity while maintaining anticancer potency. We synthesized novel apoferritin- and liposome-encapsulated forms of doxorubicin ("Apodox" and "lip-8-dox") and compared its toxicity with doxorubicin and My...

Journal: :Cancer research 2003
Shairoz Ramji Chunja Lee Tadanobu Inaba Adam V Patterson David S Riddick

Doxorubicin is a useful antineoplastic drug with multiple mechanisms of cytotoxicity. One such mechanism involves the reductive bioactivation of the quinone ring to a semiquinone radical, which can exert direct toxic effects and/or undergo redox cycling. We hypothesized that human NADPH-cytochrome p450 reductase (CYPRED) catalyzes doxorubicin reduction and that overexpression of this enzyme sen...

Journal: :Indian Journal of Pharmaceutical Education and Research 2022

Abstract: Background and Objectives: Myocardial ischemia is one of the leading causes deaths among cardiac pathological conditions. Doxorubicin belongs to anthracycline class drug which effective against a wide variety neoplasms. However, doxorubicininduced cardiotoxicity limits clinical utility drug. One major myocardial oxidative stress. Adhatoda vasica have been shown possess strong anti-inf...

Journal: :research in pharmaceutical sciences 0

single-walled carbon nanotubes (swnts) are among the promising nano-devices for delivery of therapeutic agents. yet the drastic hydrophobic natures of swnts make their handling and hence application difficult.several researches have been conducted to make them more hydrophilic and water dispersible and less toxic. among the different approaches, dispersion methods exploit different reagents suc...

Journal: :Circulation 2009
Wuqiang Zhu Mark H Soonpaa Hanying Chen Weihua Shen R Mark Payne Edward A Liechty Randall L Caldwell Weinian Shou Loren J Field

BACKGROUND Doxorubicin is used to treat childhood and adult cancer. Doxorubicin treatment is associated with both acute and chronic cardiotoxicity. The cardiotoxic effects of doxorubicin are cumulative, which limits its chemotherapeutic dose. Free radical generation and p53-dependent apoptosis are thought to contribute to doxorubicin-induced cardiotoxicity. METHODS AND RESULTS Adult transgeni...

Journal: :Circulation research 2016
Hai Ying Fu Shoji Sanada Takashi Matsuzaki Yulin Liao Keiji Okuda Masaki Yamato Shota Tsuchida Ryo Araki Yoshihiro Asano Hiroshi Asanuma Masanori Asakura Brent A French Yasushi Sakata Masafumi Kitakaze Tetsuo Minamino

RATIONALE Doxorubicin is an effective chemotherapeutic agent for cancer, but its use is often limited by cardiotoxicity. Doxorubicin causes endoplasmic reticulum (ER) dilation in cardiomyocytes, and we have demonstrated that ER stress plays important roles in the pathophysiology of heart failure. OBJECTIVE We evaluated the role of ER stress in doxorubicin-induced cardiotoxicity and examined w...

Journal: :Biochemical and biophysical research communications 2006
Simone Grethe Nadia Coltella Maria Flavia Di Renzo M Isabella Pörn-Ares

Doxorubicin is the anthracycline with the widest spectrum of antitumor activity, and it has been shown that the antitumor activity is mediated in vivo by selective triggering of apoptosis in proliferating endothelial cells. We studied cultured human endothelial cells and observed that doxorubicin-induced apoptosis was mediated by p38 mitogen-activated protein kinase (MAPK). Doxorubicin-provoked...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید